Clinical Trials for High Risk Smoldering Myeloma Patients
Clinical Trials for High Risk Smoldering Myeloma Patients image
Jul 05, 2021 / 07:00PM - 08:00PM EDT
MGUS/Smoldering Myeloma Chapter

Event Description

Be proactive in your care by learning about what clinical trials are available to you. No matter where you are in the precursor journey, learning about these trials now can help prepare you for what might come in your future. Multiple Myeloma Specialist, Dr. Jeffrey Zonder, will share his experience in high-risk clinical trials and explain their importance in the future of myeloma. 

Schedule & Agenda

person
Introductions
07:00PM
Audrey Burton-Bethke
Audrey welcomes everybody, shares the event agenda, and introduces our featured speaker.
person
Presentation
07:05PM
Jeffrey Zonder, M.D.
Dr. Zonder shares his experience in high-risk clinical trials and explains their importance in the future of myeloma. 
person
Q&A
07:35PM
Audience
Ask Dr. Zonder your questions about his presentation and clinical trials for high-risk smoldering myeloma patients.

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Jeffrey Zonder, M.D.
Jeffrey Zonder, M.D.

Professor in the Departments of Oncology at the Barbara Ann Karmanos Cancer Institute (KCI) and Wayne State University School of Medicine. He is the leader of the KCI Multiple Myeloma and Amyloidosis Multidisciplinary Team and co-leader of Molecular Therapeutic Program. He is e member of the Steering Committee at the Multiple Myeloma Research Consortium, a medical advisor for the Amyloidosis Support Group Networks, and a member of the International Myeloma Working Group, the International Myeloma Society and the International Amyloidosis Society. He is a member of the Southwest Oncology Group’s (SWOG) Barlogie-Salmon Myeloma Committee. Dr. Zonder has authored or co-authored numerous original research papers, review articles, book chapters, and research abstracts on myeloma and amyloidosis. He completed a fellowship in hematology-oncology at Wayne State University and his medical residency at the University of Rochester, New York. He received his medical degree from Wayne State University School of Medicine.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811